The global orthopedic hyaluronic acid market is expected to grow at a significant CAGR during the forecast period. The key factor contributing to the growth of the global orthopedic hyaluronic acid market include the rising geriatric population and growing prevalence of knee osteoarthritis. Furthermore, exponential growth in healthcare expenditure by countries enhanced healthcare quality, and growing R&D investments by pharmaceutical firms are propelling the growth of the market. According to the World Population Prospects 2019, by the US Population Division, approximately 9.32% of the total population in 2019 was over 65 years of age. 

Hyaluronic acid is the naturally occurring substance in the body and is present in high concentrations in the eyes and joints. Hyaluronic acid injections are approved by the US FDA for the treatment of knee osteoarthritis and also for the treatment of cataracts.  According to the Centers for Disease Control and Prevention, around 32.5 million US adults suffer from osteoarthritis in 2020.

The key players contributing to the growth of the global orthopedic hyaluronic acid market by adopting various strategies such as product launches & developments, mergers and acquisition, partnerships, and agreements, include Anika Therapeutics, Inc., LG chem., Smith & Nephew Plc, Seikagaku Corp., Lifecore Biomedical, LLC, Sanofi S.A., Zimmer Biomet Holdings, Inc., and others. For instance, in December 2019, Fidia Pharma US Inc. a subsidiary of the Fidia Pharma introduced intra-articular Hyaluronic acid injections under the brand name TRILURON, for the treatment of pain in knee osteoarthritis resistant to traditional non-pharmacologic therapy and simple analgesics. Furthermore, in April 2020, JTA-004, a plasma protein solution supplemented with hyaluronic acid developed in a single intra-articular injection by Bone Therapeutics S.A., had entered phase 3 clinical trials for the treatment of knee osteoarthritis. 

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Product

o By Application

• Regions covered-

o North America

o Europe

o Asia Pacific

o Rest of the World

• Competitive Landscape- Anika Therapeutics, Inc., LG chem., Smith & Nephew Plc, Seikagaku Corp., Lifecore Biomedical, LLC, Sanofi S.A., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Orthopedic Hyaluronic Acid Market by Segments

By Product

• Single-Injection
• Three-Injection
• Five-Injection

By Application

• Knee
• Hip
• Ankle
• Others(Shoulder, Spine)

Global Orthopedic Hyaluronic Acid Market by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa